Related Experiment Video
Updated: Jun 3, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
Inclusion body myositis: diagnosis, pathogenesis, and treatment options
Guillermo E Solorzano1, Lawrence H Phillips
1Department of Neurology, University of Virginia School of Medicine, PO Box 800394, Charlottesville, VA 22908-0394, USA. ges3b@virginia.edu
Abstract:
Inclusion body myositis (IBM) is the most common acquired myopathy in people older than 50 years. IBM typically presents with distal upper extremity weakness accompanied by proximal lower extremity muscle weakness. Associated clinical findings include asymmetric weakness, foot drop, and dysphagia. The pathogenesis of IBM is not clear. In this article the authors briefly discuss postulated pathogenic mechanisms. Although no proven pharmacotherapy exists, some promising candidates are discussed.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myocarditis III: Medical Management
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
